Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yuxin Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Sciences, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Berberine, DNA Ligase ATP, Radiation Tolerance, Radiation-Sensitizing Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education of Liaoning Province, Dalian Medical University Interdisciplinary Research Cooperation Project, Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Berberine (BBR) is an isoquinoline alkaloid with a variety of biological activities, including anti‐microbial and anti‐tumoral activities. However, the cellular targets of BBR and the roles of BBR in the radiosensitivity of breast cancer cells are not well defined. In this study, we investigated the effects of BBR on the radiosensitivity of BT549 triple‐negative breast cancer cells. Through RNA‐seq results, we found that BBR significantly down‐regulated the expression of DNA ligases. The results of western blot and comet assay confirmed that BBR attenuated DNA ligase III (LIGIII) expression and caused DNA damage in a dose‐dependent manner. The results of electron microscopy showed that BBR decreased mitochondrial copies and induced mitochondrial autophagy. Clonal formation analysis showed that BBR sensitised breast cancer cells to irradiation. The genetic complementation and interference assays showed that the effect of BBR on the radiosensitivity of BT549 breast cancer cells is dependent on the expression of LIGIII. These results contribute to the understanding of the effects of BBR on cellular DNA repair and the clinical application of BBR in breast cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
- Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
ORCID-Profile: Weifeng Mao
Förderung
- Department of Education of Liaoning Province
- Dalian Medical University Interdisciplinary Research Cooperation Project
- Wu Jieping Medical Foundation
- Youth Talent Cultivation Project of Dalian Medical University
Zitieren
APA
Sun, Y., Li, C., Yin, H., Li, K., Wang, Y., Zhang, S., Zhao, Y., Wang, J., & Mao, W. (2025). Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70836
Vancouver
Sun Y, Li C, Yin H, Li K, Wang Y, Zhang S, et al. Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70836
BibTeX
@article{Sun2025,
author = {Sun, Yuxin and Li, Cong and Yin, Hang and Li, Kunyan and Wang, Ying and Zhang, Shuailong and Zhao, Yi and Wang, Jing and Mao, Weifeng},
title = {Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70836}
}
EUVIMED